Huanyu Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Huanyu Meng has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jing Pan
Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
1 shared publication - Jun Liu
Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Lijun Wang
Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China
1 shared publication - Lili Zeng
Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Zhao Yang
Department of Neurology, Ruijin North Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
1 shared publication
Latest Publications
- Open Access
- 20 November 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (11) , 1587
Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy
Patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) seropositive for autoantibodies against nodal and paranodal proteins display distinct clinical presentations. In the latest study, CIDP with autoantibodies against paranodal proteins was defined as autoimmune nodopathy (AN). We herein present a case of 39-year-old male with anti- neurofascin (NF) 155 and NF186 IgG4 antibody with gait disturbance and tremor, who was followed up for 4 months and demonstrated clinical improvements after apparently effective rituximab therapy. In addition, a literature review was conducted to investigate the clinical characteristics of anti-NF155/NF186-positive AN.
- 20 November 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (11) , 1587
Open AccessAnti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy
Patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) seropositive for autoantibodies against nodal and paranodal proteins display distinct clinical presentations. In the latest study, CIDP with autoantibodies against paranodal proteins was defined as autoimmune nodopathy (AN). We herein present a case of 39-year-old male with anti- neurofascin (NF) 155 and NF186 IgG4 antibody with gait disturbance and tremor, who was followed up for 4 months and demonstrated clinical improvements after apparently effective rituximab therapy. In addition, a literature review was conducted to investigate the clinical characteristics of anti-NF155/NF186-positive AN.